BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28005691)

  • 1. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
    Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
    Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
    Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant
    Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
    Front Public Health; 2022; 10():983174. PubMed ID: 36091556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
    Baran I; Aksu N
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare cause of infection, Raoultella planticola: emerging threat and new reservoir for carbapenem resistance.
    Demiray T; Koroglu M; Ozbek A; Altindis M
    Infection; 2016 Dec; 44(6):713-717. PubMed ID: 27147419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States.
    Pannaraj PS; Bard JD; Cerini C; Weissman SJ
    Pediatr Infect Dis J; 2015 Jan; 34(1):11-6. PubMed ID: 25093977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
    Guh AY; Bulens SN; Mu Y; Jacob JT; Reno J; Scott J; Wilson LE; Vaeth E; Lynfield R; Shaw KM; Vagnone PM; Bamberg WM; Janelle SJ; Dumyati G; Concannon C; Beldavs Z; Cunningham M; Cassidy PM; Phipps EC; Kenslow N; Travis T; Lonsway D; Rasheed JK; Limbago BM; Kallen AJ
    JAMA; 2015 Oct; 314(14):1479-87. PubMed ID: 26436831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy.
    Caselli D; Cesaro S; Fagioli F; Carraro F; Ziino O; Zanazzo G; Meazza C; Colombini A; Castagnola E;
    Infect Dis (Lond); 2016 Feb; 48(2):152-5. PubMed ID: 26393496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
    Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
    Drew RJ; Turton JF; Hill RL; Livermore DM; Woodford N; Paulus S; Cunliffe NA
    J Hosp Infect; 2013 Aug; 84(4):300-4. PubMed ID: 23831281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    Ara-Montojo MF; Escosa-García L; Alguacil-Guillén M; Seara N; Zozaya C; Plaza D; Schuffelmann-Gutiérrez C; de la Vega Á; Fernández-Camblor C; Ramos-Boluda E; Romero-Gómez MP; Ruiz-Carrascoso G; Losantos-García I; Mellado-Peña MJ; Gómez-Gil R
    J Antimicrob Chemother; 2021 Jan; 76(1):220-225. PubMed ID: 33038895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
    Balkan II; Aygün G; Aydın S; Mutcalı SI; Kara Z; Kuşkucu M; Midilli K; Şemen V; Aras S; Yemişen M; Mete B; Özaras R; Saltoğlu N; Tabak F; Öztürk R
    Int J Infect Dis; 2014 Sep; 26():51-6. PubMed ID: 24998423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and epidemiologic predictors of blood stream infections with New Delhi Metallo-b-lactamase (NDM-1) producing Enterobacteriaceae.
    Snyder BM; Montague BT; Anandan S; Madabhushi AG; Pragasam AK; Verghese VP; Balaji V; Simões EAF
    Epidemiol Infect; 2019 Jan; 147():e137. PubMed ID: 30869056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.